Associate Prof. (Dr.) U K Mandal

About

Dr. Uttam Kumar Mandal is Associate Professor at Department of Pharmaceutical Sciences & Technology, Maharaja Ranjit Singh Punjab Technical University (MRSPTU), Punjab, India. He has 9 years of teaching experience (out of which 5 years in IIUM, Malaysia), 10 years of research experience (out of which two years as Post-doctoral Fellow at University of Geneva, Switzerland). His research interest includes drug delivery, development of transdermal nanoformulations (transfersomes, ethosomes, niosomes), solubility enhancement, modern analytical techniques, bioavailability & bioequivalence, wound healing. Based on his diverse fields of research experiences, he has published more than seventy (70) research papers in various high impact factor journals. His aim is to be a distinguished drug delivery researcher and wish to develop patient friendlyand cost effective medicinal products.

Employment

• Maharaja Ranjit Singh Punjab Technical University (MRSPTU) Associate Professor
  2016 - Present
• iKOP Sdn. Bhd. HOD, R&D
  2012 - 2016
• International Islamic University Malaysia Assistant Professor
  2011 - 2016
• National Institute of Pharmaceutical Education & Research (NIPER) Assistant Professor
  2010 - 2011
• University of Geneva Post-doctoral Fellow
  2008 - 2010
• Bioequivalence Study Centre, Jadavpur University Chief Analytical Chemist
  2003 - 2008
• Indchemie Health Spl. Pvt. Ltd. QC & QA Chemist
  2001 - 2002
• Sun Pharmaceutical Industries Ltd Trainee Production Chemist
  2000 - 2001
• AIMCO Pharmaceutical Mfg. Co. Production Chemist
  2000 - 2000
• Gelikeps Pvt. Ltd. Production Chemist
  1999 - 2000
• Mercury Antibiotics Pvt. Ltd. Production Chemist
  1998 - 1999

Education

• Jaadavpur University PhD
  2004 - 2008
• Jadavpur University M. Pharm
  2002 - 2004
• Jadavpur University B. Pharm
  1994 - 1998

Projects & Funding

Projects & funding information is unavailable.

Publications (166)

• Preservatives in Pharmaceuticals: Are They Really Safe?
  Current Drug Safety 2023 DOI: 10.2174/1574886317666220919121532
  +Save
• Recent Reviews on Dendrimers as an Immunotherapy-based Nanosystem for the Effective Treatment of Cancer
  Drug Delivery Letters 2022 DOI: 10.2174/2210303112666220422102459
  +Save
• A Recent Review On 3D-Printing: Scope and Challenges with Special Focus on Pharmaceutical Field
  Current Pharmaceutical Design 2022 DOI: 10.2174/1381612828666220623091629
  +Save
• Nanomaterial-based delivery of vaccine through nasal route: Opportunities, challenges, advantages, and limitations
  Journal of Drug Delivery Science and Technology 2022 DOI: 10.1016/j.jddst.2022.103533
  +Save
• An Updated Account on Formulations and Strategies for the Treatment of Burn Infection – A Review
  Current Pharmaceutical Design 2022 DOI: 10.2174/1381612828666220519145859
  +Save
• Recent Applications of Derivatization Techniques for Pharmaceutical and Bioanalytical Analysis through High-performance Liquid Chromatography
  Current Analytical Chemistry 2022 DOI: 10.2174/1573411017666211108092115
  +Save
• Sustained release matrix tablet of 100 mg losartan potassium: Formulation development and in vitro characterization
  Brazilian Journal of Pharmaceutical Sciences 2022 DOI: 10.1590/s2175-97902022e20079
  +Save
• In-vitro Dissolution Study of Pharmaceutical Products with USP Apparatus- IV
  Drug Delivery Letters 2021 DOI: 10.2174/2210303111666210712101322
  +Save
• Review on Disease, Dose, Destination and Delivery Aspects of Simvastatin
  Drug Delivery Letters 2020 DOI: 10.2174/2210303110999200730215812
  +Save
• Development and Validation of a UV Spectrophotometric method of Mycophenolate mofetil useful at Preformulation stage of Microemulsion Formulation
  Research Journal of Pharmacy and Technology 2019 DOI: 10.5958/0974-360x.2019.00824.2
  +Save